Peng, Y., Dong, P., Han, H., Zhou, F., Zhang, Z. (2025). Cadonilimab combined with lenvatinib for neoadjuvant therapy in early-stage renal cell carcinoma with indications for partial nephrectomy but high surgical risk: A prospective single-arm phase II clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.530